About Us

By harnessing insights from human genetics, neuroscience, and immunology, we’re advancing innovative therapies with the potential to counteract the devastating progression of neurodegenerative diseases.

Through rigorous science, technology development, deep curiosity, and a determination to make a difference, we’re building an ambitious pipeline of therapeutic candidates designed to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function.

By combining deep expertise in drug development, protein and nucleic acid engineering, antibody discovery, neuroscience, with our proprietary Alector Brain Carrier (ABC) technology, we are advancing a pipeline of potential therapies designed to address critical unmet needs in neurodegenerative disease.

At Alector, we aren’t just developing therapeutics – we aim to make brain disorders history. Because we believe that every mind deserves a lifetime.